H. Pennings (Roermond, Netherlands), J. C. Virchow (Rostock, Germany)
Identification of COPD phenotypes using cluster analysis including exhaled air molecular profiling
N. Fens, A. G. J. van Rossum, P. Zanen, B. van Ginneken, R. J. van Klaveren, A. H. Zwinderman, P. J. Sterk (Amsterdam, Utrecht, Rotterdam, Netherlands)
|  |
Smoking and exhaled NO concentration in patients with COPD
L. Konopkina, T. Pertseva, N. Efimova, K. Gashynova, N. Klimenko (Dnopropetrovs'k, Ukraine)
|  |
COPD: Exhaled NO concentration and its prognostic value for smoking patient
T. Pertseva, K. Gashynova, N. Efimova (Dnipropetrovsk, Ukraine)
| |
The comparison of multidimensional staging systems for COPD
A. Corlateanu, C. Cote, V. Botnaru, O. Ciobanu (Chisinau, Republic Of Moldova; , United States Of America)
| |
Measurement of urinary total desmosine and isodesmosine using isotope-dilution liquid chromatography-tandem mass spectrometry
O. Albarbarawi, A. Barton, Z. Lin, E. Takahashi, A. Buddharaju, J. Brady, D. Miller, C. Palmer, J. T. J. Huang (Dundee, United Kingdom)
| |
The impact of ²open door² spirometry on diagnosis of obstructive lung diseases
V. Andreev (Pleven, Bulgaria)
| |
Daily tele-monitoring of symptoms and spirometry in chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) – A comparative study
N. Jarad, Z. Sund (Bristol, United Kingdom)
| |
Global Alliance against Chronic Respiratory Diseases (GARD) program in Georgia: The results of the pilot study
I. Chkhaidze, T. Maglakelidze, N. Khaltaev (Georgia; Geneva, Switzerland)
| |
Physical activity is associated with ultrasound measurement of rectus femoris cross-sectional area and quadriceps strength independent of FEV1 in COPD
D. Shrikrishna, J. Kelly, G. Coissi, P. Murphy, Z. A. Puthucheary, J. M. Seymour, N. Hart, J. Moxham, M. I. Polkey, N. Hopkinson (London, United Kingdom)
| |
Mechanisms of resistance to COPD at hard-core smokers
E. Bukreeva, G. Seitova, T. Melnik, O. Akbasheva, S. Nesterovich (Tomsk, Russian Federation)
| |
The economic burden of chronic obstructive pulmonary disease
S. Altin, A. Uysal, L. Kilic (Istanbul, Turkey)
| |
Comparison of prevalence of COPD in tobacco users in two regions: Region with high, and region with low level of air pollution
G. Andonovski, Z. Stojanovski, J. Minov, S. Andjelkovic (Skopje, Kumanovo, Fyrom)
| |
COPD in Buenos Aires: Screening the community during COPD day
R. Gene, G. Appelbaum, I. Boyeras, G. Lonegro, R. Aguirre, V. Giovini, M. Otaola, L. Rolando (Buenos Aires, Argentina)
| |
Clinical relevance of bronchiectasis in COPD
D. de la Rosa, I. Carrasco, A. Varez, A. Ocanya, N. Roldan, R. Martinez (Barcelona, El Masnou, La Laguna, Spain)
| |
The Bronchiectasis Research Registry: Clinical, microbiologic, and treatment characteristics
A. O‘Donnell, D. R. Prevots, K. Olivier, L. Lavange, B. Thomashow, M. Knowles, C. Daley, T. Aksamit (Washington, Bethesda, Chapel Hill, New York, Denver, Rochester, United States Of America)
| |
Efficacy of long-term educational program (EP) of patients with COPD
L. Botvinikova, L. Konopkina, A. Garagulya (Dnopropetrovs'k, Ukraine)
| |
Influence of educational program on the quality of life of patients with COPD of moderate severity
A. Y. Trofimova, A. V. Kolosov (Blagoveshchensk, Russian Federation)
| |
The "rapid decliner" COPD phenotype
I. Cerveri, A. G. Corsico, R. Niniano, V. Ronzoni, R. Cavalli, A. Grosso, A. Foresi, F. Imberti, T. Galasso, E. Tsana Tegomo, E. Pozzi (Pavia, Italy)
| |
Peripheral neuropathy in chronic obstructive pulmonary disease
S. Baser, C. Oncel, M. Cam, B. Akdag, F. Evyapan (Denizli, Turkey)
| |